Oxbridge Re FY2026 Earnings Forecast Reduced by Maxim Group

Oxbridge Re Holdings Limited (NASDAQ:OXBR – Free Report) – Maxim Group lowered their FY2026 earnings per share (EPS) estimates for Oxbridge Re in a research note issued on Tuesday, November 10th. Maxim Group analyst A. Klee now anticipates that the insurance provider will earn ($0.10) per share for the year, down from their prior forecast of ($0.04). The consensus estimate for Oxbridge Re’s current full-year earnings is ($0.10) per share. Maxim Group also issued estimates for Oxbridge Re’s Q4 2026 earnings at ($0.07) EPS, Q1 2027 earnings at ($0.10) EPS, Q3 2027 earnings at ($0.10) EPS, Q4 2027 earnings at ($0.10) EPS and FY2027 earnings at ($0.30) EPS.

Oxbridge Re (NASDAQ:OXBR – Get Free Report) last announced its earnings results on Monday, November 9th. The insurance provider reported ($0.05) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.05). Oxbridge Re had a negative return on equity of 1.63% and a negative net margin of 4.29%. The business had revenue of $0.26 million for the quarter, compared to analysts’ expectations of $0.40 million.

A number of other equities research analysts also recently weighed in on the company. Zacks Research raised Oxbridge Re from a “strong sell” rating to a “hold” rating in a research report on Friday, October 16th. Weiss Ratings reiterated a “sell (d+)” rating on shares of Oxbridge Re in a report on Thursday. One equities research analyst has rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Oxbridge Re has an average rating of “Hold” and an average target price of $3.00.

Get Our Latest Analysis on OXBR

Oxbridge Re Price Performance

OXBR opened at $0.88 on Thursday. Oxbridge Re has a 12 month low of $0.65 and a 12 month high of $1.86. The stock has a fifty day moving average price of $1.10 and a 200-day moving average price of $1.09.

Institutional Investors Weigh In On Oxbridge Re

An institutional investor recently bought a new stake in Oxbridge Re stock. Citadel Advisors LLC bought a new stake in Oxbridge Re Holdings Limited (NASDAQ:OXBR – Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 65,855 shares of the insurance provider’s stock, valued at approximately $68,000. Citadel Advisors LLC owned approximately 0.81% of Oxbridge Re as of its most recent SEC filing. 5.64% of the stock is owned by hedge funds and other institutional investors.

Oxbridge Re Company Profile

(Get Free Report)

Oxbridge Re Holdings Limited is a specialty reinsurance holding company listed on the Nasdaq Capital Market under the symbol OXBR. The company conducts its reinsurance activities primarily through Oxbridge Reinsurance Limited, a Bermuda-based subsidiary, and focuses on providing collateralized property catastrophe reinsurance. Its coverage is designed to protect insurance companies against losses from major natural-catastrophe events, including hurricanes and other severe weather-related disasters.

Read More

Earnings History and Estimates for Oxbridge Re (NASDAQ:OXBR)

Receive News & Ratings for Oxbridge Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxbridge Re and related companies with MarketBeat.com's FREE daily email newsletter.